Description of Qc Technologies Inc's Business Segments

The company's reportable segment comprises its therapeutic development programs, including Isomyosamine and Supera-CBD. Isomyosamine is a clinical-stage small molecule targeting the immunometabolic system to treat autoimmune diseases such as sarcopenia, frailty, adverse effects of diabetes and obesity treatments, rheumatoid arthritis, and inflammatory bowel disease, with an initial focus on age-related frailty and sarcopenia. It functions by regulating the release of pro-inflammatory cytokines, including TNF-α, IL-6, and IL-17. Supera-CBD is a synthetic analog of CBD designed to address conditions such as epilepsy, pain, and anxiety/depression by acting on the CB2 receptor, opioid receptors, and the MAO type B enzyme. The company's legacy pharmaceutical business has involved preclinical testing, clinical trial planning and execution, regulatory submissions, and intellectual property development. It continues to maintain its intellectual property portfolio and certain operational capabilities. The company is currently evaluating strategic alternatives for this legacy pharmaceutical business, which may include divestitures, licensing transactions, partnerships, or other arrangements, with the objective of optimizing asset value and concentrating resources on its laser-based computing business. This legacy pharmaceutical segment faces significant risks, including clinical development uncertainty, potential adverse regulatory outcomes, and substantial capital requirements. Its future depends on the results of the company's strategic review and its ability to complete transactions or partnerships.

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.